Delcath Systems (NASDAQ:DCTH) is one of today's best performing low-priced stocks, up 5.6% to $1.51 on 1.3x average daily volume. Thus far today, Delcath Systems has traded 1.6 million shares, vs. average volume of 1.3 million shares per day. The stock has outperformed the Dow (5.6% to the Dow's -0.2%) and outperformed the S&P 500 (5.6% to the S&P's -0.2%) during today's trading.

Delcath Systems Inc. has developed a system to isolate the liver from the circulatory system and to administer chemotherapy and other therapeutic agents directly to the liver. This system filters the patients blood removing most of the harmful chemotherapy agents lessening the side-effects of the treatment.

In the past 52 weeks, Delcath Systems share prices have been bracketed by a low of $1.01 and a high of $9.70 and are now at $1.51, 50% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 1.3% while the 200-day MA has slid 1.3%.

There is potential upside of 215.4% for shares of Delcath Systems based on a current price of $1.51 and an average consensus analyst price target of $4.76. The stock should hit resistance at its 200-day moving average (MA) of $1.76, as well as support at its 50-day MA of $1.35.

SmarTrend is tracking the current trend status for Delcath Systems and will alert subscribers who have DCTH in their portfolio or watchlist when shares have changed trend direction.